Good points, tc. Small biotechs have a hard time getting attention from the FDA and big pharma. Joe thinks Kiromics is on the cutting edge of research and AE has never disappointed, although it has a long way to go. Agree it’s best to just enjoy the ride. We’ve had much to enjoy over the past 9 moths or so.